Pioneering neuromodulation therapy for chronic migraine
Salvia BioElectronics is pioneering a breakthrough therapy to transform chronic migraine treatment. MySalvia Therapy features an ultra-thin, unnoticeable implant designed to calm key nerves involved in migraine, activated with a simple tap on a small wearable device. Built for everyday life, it is developed to deliver drug-free relief without compromise. So, millions of people with migraine can live life, uninterrupted.
Founded in 2017 in Europe’s tech capital Eindhoven, Salvia brings together skilled device makers and MedTech entrepreneurs with extensive experience in medical devices and neuromodulation. Active in the United States, Europe, and Australia, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its innovative technology for the treatment of cluster headache.
Salvia’s migraine therapy is currently being evaluated in clinical studies. It has not yet been approved for commercial use. No claims are made regarding its safety or effectiveness.
Meet our team
Salvia BioElectronics has experienced remarkable growth over the past eight years. We now have more than 50 colleagues from all over the world, representing 18 nationalities.
Our home is High Tech Campus Eindhoven, also known as the smartest square kilometer in Europe, where more than 300 high-tech companies are developing the technologies of the future.
Salvia BioElectronics secures $60M in oversubscribed Series B to bring its pioneering migraine therapy to market
Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the successful completion of a $60 million (€53 million) Series B financing round.
It is not “just a headache”
Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Cluster headache, which causes excruciating pain behind the eye, is a rare neurological disorder affecting 1 in 1000 people. Read more about both conditions we address with our bioelectronic solution.
Join our team
Our team is growing and we are always looking for passionate and talented individuals who want to be part of our mission to give people with migraine a better life.
We also encourage open applications; please submit yours here!
Acquisition is not appreciated.
Field Clinical Engineer
Do you enjoy combining technical expertise with meaningful human impact?
Are you motivated by the idea of helping patients benefit from breakthrough therapies?
As a Field Clinical Engineer at Salvia BioElectronics, you’ll play a key role in the success of our clinical trials. From supporting implant procedures and patient follow-ups to ensuring smooth trial operations, your work will help bring innovative neuromodulation therapies closer to people living with migraine. Every step you take contributes directly to transforming lives.
Quality Engineer
This is an exciting opportunity to contribute to a fast-paced, purpose-driven company at the forefront of neuromodulation technology. Closely collaborating with Salvia’s multidisciplinary team, you take ownership and have a pragmatic approach.
Supply Chain Assistant
Would you like to contribute to the development and production of innovative medical devices that make a real difference for patients suffering from chronic migraine?
At Salvia BioElectronics BV in Eindhoven, we are looking for a Supply Chain Assistant (32–40 hours per week) to strengthen our team. In this role, you will support and manage material flows, from consumables and components to subassemblies and finished goods. Your work ensures that our production and development teams always have the right materials available — at the right time, with the right documentation.
You will join a dynamic, multidisciplinary team at the heart of a growing scale-up. With your structured mindset, organizational talent, and discipline, you will play an essential role in our operations and help us scale up to serve more patients worldwide.
Stay informed
Salvia BioElectronics strengthens Board of Directors with industry leader Rob ten Hoedt
“Joining Salvia’s Board of Directors is a great opportunity to support the advancement of a pioneering medtech approach with the potential to address a significant unmet medical need,” said Rob ten Hoedt, Member of Salvia’s Board of Directors.
Salvia BioElectronics secures $60M in oversubscribed Series B to bring its pioneering migraine therapy to market
Salvia BioElectronics, a clinical-stage medical device company pioneering neuromodulation therapy for people with chronic migraine, today announced the successful completion of a $60 million (€53 million) Series B financing round.
.avif)
Founders with a mission: the story behind Salvia BioElectronics
Get to know the people behind Salvia, and the journey that brought them here.
Meet our investors
Salvia Insights
Later in 2025, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?
We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.